Literature DB >> 32691145

A toddler with severe hypercalcemia and pyelonephritis: Answers.

Joseph Wilbanks1, Jessica Hillyer2, Faris Hashim3, David Sas4, Christian Hanna4.   

Abstract

Entities:  

Keywords:  24-Hydroxylase deficiency; CYP24A1; Hypercalcemia; Idiopathic infantile hypercalcemia; Infant; Nephrocalcinosis; Pyelonephritis

Year:  2020        PMID： 32691145     DOI： 10.1007/s00467-020-04711-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  10 in total

Review 1.  Hypercalcemia in children and adolescents.

Authors:  Steven A Lietman; Emily L Germain-Lee; Michael A Levine
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

Review 2.  Narrative review: furosemide for hypercalcemia: an unproven yet common practice.

Authors:  Susan B LeGrand; Dona Leskuski; Ivan Zama
Journal:  Ann Intern Med       Date:  2008-08-19       Impact factor: 25.391

3.  Mutations in CYP24A1 and idiopathic infantile hypercalcemia.

Authors:  Karl P Schlingmann; Martin Kaufmann; Stefanie Weber; Andrew Irwin; Caroline Goos; Ulrike John; Joachim Misselwitz; Günter Klaus; Eberhard Kuwertz-Bröking; Henry Fehrenbach; Anne M Wingen; Tülay Güran; Joost G Hoenderop; René J Bindels; David E Prosser; Glenville Jones; Martin Konrad
Journal:  N Engl J Med       Date:  2011-06-15       Impact factor: 91.245

Review 4.  Hypercalcemia: a consultant's approach.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2017-09-06       Impact factor: 3.714

5.  CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.

Authors:  Colin Patrick Hawkes; Dong Li; Hakon Hakonarson; Kevin E Meyers; Kenneth E Thummel; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

Review 6.  The use of bisphosphonates in pediatrics.

Authors:  Giampiero I Baroncelli; Silvano Bertelloni
Journal:  Horm Res Paediatr       Date:  2014-11-06       Impact factor: 2.852

7.  Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.

Authors:  Dganit Dinour; Pazit Beckerman; Liat Ganon; Karen Tordjman; Zemach Eisenstein; Eli J Holtzman
Journal:  J Urol       Date:  2013-03-05       Impact factor: 7.450

8.  CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.

Authors:  A Molin; R Baudoin; M Kaufmann; J C Souberbielle; A Ryckewaert; M C Vantyghem; P Eckart; J Bacchetta; G Deschenes; G Kesler-Roussey; N Coudray; N Richard; M Wraich; Q Bonafiglia; A Tiulpakov; G Jones; M-L Kottler
Journal:  J Clin Endocrinol Metab       Date:  2015-07-27       Impact factor: 5.958

9.  Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake.

Authors:  Dganit Dinour; Miriam Davidovits; Shraga Aviner; Liat Ganon; Leonid Michael; Dalit Modan-Moses; Iris Vered; Haim Bibi; Yaacov Frishberg; Eli J Holtzman
Journal:  Pediatr Nephrol       Date:  2014-09-07       Impact factor: 3.714

10.  Idiopathic hypercalciuria in children with urinary tract infection.

Authors:  Alejandro Balestracci; Luciana Meni Battaglia; Ismael Toledo; Sandra Mariel Martin; Raquel Eva Wainsztein
Journal:  Arch Argent Pediatr       Date:  2014-10       Impact factor: 0.694
  10 in total
  1 in total

1.  Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease.

Authors:  Andrea G Cogal; Jennifer Arroyo; Ronak Jagdeep Shah; Kalina J Reese; Brenna N Walton; Laura M Reynolds; Gabrielle N Kennedy; Barbara M Seide; Sarah R Senum; Michelle Baum; Stephen B Erickson; Sujatha Jagadeesh; Neveen A Soliman; David S Goldfarb; Lada Beara-Lasic; Vidar O Edvardsson; Runolfur Palsson; Dawn S Milliner; David J Sas; John C Lieske; Peter C Harris
Journal:  Kidney Int Rep       Date:  2021-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.